Urinary Metabolic Biomarkers of Attentional Control in Children With Attention-Deficit/Hyperactivity Disorder: A Dimensional Approach Through 1H NMR-Based Metabolomics
- PMID: 40599064
- PMCID: PMC12215226
- DOI: 10.1002/nbm.70088
Urinary Metabolic Biomarkers of Attentional Control in Children With Attention-Deficit/Hyperactivity Disorder: A Dimensional Approach Through 1H NMR-Based Metabolomics
Abstract
Enhancing the understanding of attention-deficit/hyperactivity disorder (ADHD) by linking biological processes with behavioral manifestations is a primary objective of the Research Domain Criteria (RDoC) framework, which aims to transcend traditional diagnostic categories and enable a more precise understanding of mental disorders. This study aimed to replicate five data-driven profiles of attentional control in school-aged children and, for the first time, to explore associated metabolic biomarkers. Understanding these profiles and their biological underpinnings can become critical for improving ADHD diagnosis and developing new targeted interventions. A clinically well-characterized sample of 83 children with (n = 37) and without (n = 46) diagnosed ADHD completed a virtual reality continuous performance test (VR-CPT) and provided urine samples for analysis. Clustering analyses of VR-CPT data identified and replicated five distinct attentional control subgroups, two of which-ADHD-IMP and ADHD-SP-exhibited clinically significant impairments in attention and hyperactivity but opposite performance profiles in response inhibition and latency of response. NMR-based metabolomics further revealed that children in the ADHD-IMP subgroup exhibited a distinct urinary metabolic signature, with alterations in metabolites such as 3-indoxylsulfate, N-phenylacetylglycine, 3-methyl-2-oxovalerate, creatine, creatinine, pseudouridine, and trigonelline. These compounds are potentially linked to microbial activity, energy metabolism, and oxidative stress, biological pathways increasingly recognized in ADHD pathophysiology. Although no direct association emerged between these metabolites and behavioral clusters, combining both data types using machine learning, particularly Logistic Regression, substantially improved classification accuracy compared to using behavioral data alone. These findings highlight the potential of integrating behavioral and molecular markers to refine ADHD characterization and move toward more individualized approaches.
Keywords: ADHD; NMR; RDoC; VR‐CPT; cluster analysis; diagnosis; metabolomics; urine.
© 2025 The Author(s). NMR in Biomedicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Cochrane Database Syst Rev. 2011. PMID: 22161373 Free PMC article.
-
EEG-Guided Adaptive Learning: A New Neuroeducational Approach to the Facilitation of Cognitive Control in ADHD Children.Child Care Health Dev. 2025 Jul;51(4):e70113. doi: 10.1111/cch.70113. Child Care Health Dev. 2025. PMID: 40527858 Clinical Trial.
-
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2. Cochrane Database Syst Rev. 2017. PMID: 28965364 Free PMC article.
-
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2. Cochrane Database Syst Rev. 2022. PMID: 35844168 Free PMC article.
-
Methylphenidate for children and adolescents with autism spectrum disorder.Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2. Cochrane Database Syst Rev. 2017. PMID: 29159857 Free PMC article.
References
-
- American Psychiatric Association , Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (American Psychiatric Association, 2013).
MeSH terms
Substances
Grants and funding
- Consejería de Universidad, Investigación e Innovación de la Junta de Andalucía
- PID2023-147063NB-I00/Ministerio de Ciencia, Innovación y Universidades, and European Union NextGenerationEU/PRTR
- PID2021-126445OB-I00/Ministerio de Ciencia e Innovación, and European Union NextGenerationEU/PRTR
- PDC2021-121248-I00/Ministerio de Ciencia e Innovación, and European Union NextGenerationEU/PRTR
- PLEC2021-007774/Ministerio de Ciencia e Innovación, and European Union NextGenerationEU/PRTR
LinkOut - more resources
Full Text Sources
Medical